Current state of screening for bladder cancer

References

• Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J. Clin.57(1), 43–66 (2007).
   PubMed Web of Science ®Google Scholar
• Messing EM, Catalona W. Urothelial tumors of the urinary tract. In: Campbell’s Urology. 7th Edition. Walsh PC, Retik AB, Vaughan ED Jr, Wein AJ (Eds). WB Saunders Company, PA, USA 2327–2410 (1998).
   Google Scholar
• Madeb R, Messing EM. Gender, racial and age differences in bladder cancer incidence and mortality. Urol. Oncol.22, 86–92 (2004).
   PubMed Web of Science ®Google Scholar
• Aben KK, Witjes JA, Schoenberg MP, van de Hulsbergen KC, Verbeek AL, Kiemeney LA. Familial aggregation of urothelial cell carcinoma. Int. J. Cancer98, 274–278 (2002).
   PubMed Web of Science ®Google Scholar
• Halachmi S, Madeb R, Kravtsov A, Moskovitz B, Halachmi N, Nativ O. Bladder cancer – genetic overview. Med. Sci. Monit.7, 164–168 (2001).
   PubMedGoogle Scholar
• Johansson SL, Cohen SM. Epidemiology and etiology of bladder cancer. Semin. Surg. Oncol.13, 291–298 (1997).
   PubMed Web of Science ®Google Scholar
• Marcus PM, Hayes RB, Vineis P et al. Cigarette smoking N-acetyltransferase 2 acetylation status, and bladder cancer risk: a case-series meta-analysis of a gene– environment interaction. Cancer Epidemiol. Biomarkers Prev.9, 461–467 (2000).
   PubMed Web of Science ®Google Scholar
• Malkowicz SB. Management of superficial bladder cancer. In: Campbell’s Urology. 8th Edition. Walsh PC, Retik A, Vaughan ED Jr, Wein AJ. (Eds). WB Saunders Company, PA, USA 2785–2802 (2002).
   Google Scholar
• Hopkins SC, Ford KS, Soloway MS. Invasive bladder cancer: support for screening. J. Urol.130, 61–64 (1983).
   PubMed Web of Science ®Google Scholar
• Messing EM, Young TB, Hunt VB et al. Hematuria home screening: repeat testing results. J. Urol.154, 57–61 (1995).
   PubMed Web of Science ®Google Scholar
• Messing EM, Young TB, Hunt VB et al. Comparison of bladder cancer outcome in men undergoing hematuria home screening versus those with standard clinical presentations. Urology45, 387–396 (1995).
   PubMed Web of Science ®Google Scholar
• Kryger JV, Messing E. Bladder cancer screening. Semin. Oncol.23, 585–597 (1996).
   PubMed Web of Science ®Google Scholar
• Foresman WH, Messing EM. Bladder cancer: natural history, tumor markers, and early detection strategies. Semin. Surg. Oncol.13, 299–306 (1997).
   PubMedGoogle Scholar
• Botteman MF, Pashos CL, Redaelli A, Laskin B, Hauser R. The health economics of bladder cancer: a comprehensive review of the published literature. Pharmacoeconomics21, 1315–1330 (2003).
   PubMed Web of Science ®Google Scholar
• Baker S, Kessler LG, Smucker RC. Site-specific treatment costs for cancer: an analysis of the Medicare continuous history sample file. In: Cancer Care and Costs: DRG’s and Beyond. Scheffler RM, Andrews NC (Eds). Health Administration Press, MI, USA (1989).
   Google Scholar
• Riley GF, Potosky AL, Lubitz JD, Kessler LG. Medicare payments from diagnosis to death for elderly cancer patients by stage at diagnosis. Med. Care33, 828–841 (1995).
   PubMed Web of Science ®Google Scholar
• Ruttenberg R, Powers M. Economics of notification and medical screening for high-risk workers. J. Occup. Med.28, 757–764 (1986).
   PubMedGoogle Scholar
• Kaye KW, Lange PH. Mode of presentation of invasive bladder cancer: reassessment of the problem. J. Urol.128, 31–33 (1982).
   PubMed Web of Science ®Google Scholar
• Soloway MS. Progression and survival in patients with T1G3 bladder tumors. Urology59, 631 (2002).
   PubMed Web of Science ®Google Scholar
• Soloway MS, Sofer M, Vaidya A. Contemporary management of stage T1 transitional cell carcinoma of the bladder. J. Urol.167, 1573–1583 (2002).
   PubMed Web of Science ®Google Scholar
• Britton JP, Dowell AC, Whelan P. Dipstick haematuria and bladder cancer in men over 60, results of a community study. Br. Med. J.299, 1010–1012 (1989).
   PubMed Web of Science ®Google Scholar
• Britton JP, Dowell AC, Whelan P, Harris CM. A community study of bladder cancer screening by the detection of occult urinary bleeding. J. Urol.148, 788–790 (1992).
   PubMed Web of Science ®Google Scholar
• Messing EM, Young TB, Hunt VB, Wehbie JM, Rust P. Urinary tract cancers found by home screening with hematuria dipsticks in healthy men over 50 years of age. Cancer64, 2361–2367 (1989).
   PubMed Web of Science ®Google Scholar
• Messing EM, Vaillancourt A. Hematuria screening for bladder cancer. J. Occup. Med.32, 838–845 (1990).
   PubMedGoogle Scholar
• Messing EM, Young TB, Hunt VB et al. Home screening for hematuria: results of a multiclinic study. J. Urol.148, 289–292 (1992).
   PubMed Web of Science ®Google Scholar
• O’Donnell MA, Lilli K, Leopold C. Contemporary profile of superficial bladder cancer as revealed from an open-entry national muticenter study. J. Urol.171(Suppl. 4), 74 (2004).
   Google Scholar
• Messing EM, Madeb R, Young T et al. Long-term outcome of hematuria home screening for bladder cancer in men. Cancer107(9), 2173–2179 (2006).
   PubMed Web of Science ®Google Scholar
• Hemstreet GP III, Yin S, Ma Z et al. Biomarker risk assessment and bladder cancer detection in a cohort exposed to benzidine. J. Natl Cancer Inst.93, 427–436 (2001).
   PubMedGoogle Scholar
• Theriault GP, Tremblay CG, Armstrong BG. Bladder cancer screening among primary aluminum production workers in Quebec. J. Occup. Med.32, 869–872 (1990).
   PubMedGoogle Scholar
• Cartwright RA. Bladder cancer screening in the United Kingdom. J. Occup. Med.32, 878–880 (1990).
   PubMedGoogle Scholar
• Ward E, Halperin W, Thun M et al. Screening workers exposed to 4,4´-methylenebis(2-chloroaniline) for bladder cancer by cystoscopy. J. Occup. Med.32, 865–868 (1990).
   PubMedGoogle Scholar
• Marsh GM, Callahan C, Pavlock D, Leviton LC, Talbott EO, Hemstreet G. A protocol for bladder cancer screening and medical surveillance among high-risk groups: the Drake Health Registry experience. J. Occup. Med.32, 881–886 (1990).
   PubMedGoogle Scholar
• Mason TJ, Vogler WJ. Bladder cancer screening at the Dupont Chambers Works: a new initiative. J. Occup. Med.32, 874–877 (1990).
   PubMedGoogle Scholar
• Lotan Y, Svatek RS, Sagalowsky AI. Should we screen for bladder cancer in a high-risk population? A cost per life-year saved analysis. Cancer107, 982–990 (2006).
   PubMed Web of Science ®Google Scholar
• Boman H, Hedelin H, Holmang S. The results of routine evaluation of adult patients with haematuria analysed according to referral form information with 2-year follow-up. Scand. J. Urol. Nephrol.35, 497–501 (2001).
   PubMed Web of Science ®Google Scholar
• Lokeshwar VB, Soloway MS. Current bladder tumor tests: does their projected utility fulfill clinical necessity? J. Urol.165, 1067–1077 (2001).
   PubMed Web of Science ®Google Scholar
• Grossman HB, Blute ML, Dinney CP et al. The use of urine-based biomarkers in bladder cancer. Urology67, 62–64 (2006).
   PubMed Web of Science ®Google Scholar
• Grossman HB, Soloway M, Messing E et al. Surveillance for recurrent bladder cancer using a point-of-care proteomic assay. JAMA295, 299–305 (2006).
   PubMed Web of Science ®Google Scholar
• Grossman HB, Messing E, Soloway M et al. Detection of bladder cancer using a point-of-care proteomic assay. JAMA293, 810–816 (2005).
   Google Scholar
• Grossman HB. The first and second international workshops on diagnostic and prognostic markers in bladder cancer. Urol. Oncol.5, 183–184 (2000).
   PubMed Web of Science ®Google Scholar
• Messing EM. Bladder tumor markers. J. Urol.175, 1195–1196 (2006).
   PubMed Web of Science ®Google Scholar
• Nielsen ME, Schaeffer EM, Veltri RW, Schoenberg MP, Getzenberg RH. Urinary markers in the detection of bladder cancer: what’s new? Curr. Opin. Urol.16, 350–355 (2006).
   PubMed Web of Science ®Google Scholar
• Nielsen ME, Gonzalgo ML, Schoenberg MP, Getzenberg RH. Toward critical evaluation of the role(s) of molecular biomarkers in the management of bladder cancer. World J. Urol.24, 499–508 (2006).
   PubMed Web of Science ®Google Scholar
• Lokeshwar VB, Selzer MG. Urinary bladder tumor markers. Urol. Oncol.24, 528–537 (2006).
   PubMed Web of Science ®Google Scholar